Gut microbial H2S promotes metabolic dysfunction in mice via hepatic PPARα suppression
The ISME Journal · 14.01.2026 · 20 (1)
DOI: 10.1093/ismejo/wrag226 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 02.09.2026. Verfasst von Shibo Lei und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Microbiome and Health Group, Department of Microbiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410000, C…. Hauptthemen laut MEDLINE: Hydrogen Sulfide, PPAR alpha, Liver, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study investigates the role of gut microbiota-derived hydrogen sulfide (H2S) in obesity and glucose metabolism disorders. By integrating human gut metagenomic data, intervention experiments in mouse models, and in vitro cellular assays, we identified a signature of microbial sulfur metabolism in human cohorts and provided experimental evidence for its causal role and underlying metabolic mechanisms in mice. In clinical cohorts with obesity and glucose metabolism disorders, we observed a notable enrichment of genes involved in sulfur transport and H2S production. In mouse models, administration of H2S-producing Desulfovibrio desulfuricans, engineered Escherichia coli expressing phsABC, and the H2S donor NaHS consistently induced body weight gain and impaired glucose tolerance. Transcriptome analysis and cellular experiments indicated that H2S was associated with downregulation of the peroxisome proliferator-activated receptor (PPAR) signaling pathway and lipid metabolism pathways in the liver, which may contribute to the abnormal accumulation of lipids and glycogen. Furthermore, rescue experiments using a PPAR agonist and an H2S adsorbent partially reversed these metabolic abnormalities. Collectively, our work provides experimental evidence in mouse models demonstrating that gut microbial H2S promotes metabolic dysfunction through hepatic PPARα suppression, providing potential targets for microbiome-based therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Human Microbiome and Health Group, Department of Microbiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410000, China.
- Human Microbiome and Health Group, Department of Parasitology, Xiangya School of Basic Medical Sciences, Central South University, Changsha 410000, China.
- Hebei Medical University Clinical Medicine Postdoctoral Research Station, Shijiazhuang 050000, Hebei, China.
- Department of Endocrinology, Third Hospital of Hebei Medical University, Shijiazhuang 050000, Hebei, China.
- Department of Spine Surgery, The Second Xiangya Hospital, Central South University, Changsha 410000, Hunan, China.
ORCID-Profile: Jing Huang, Zheng Yu
Förderung
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
Zitieren
APA
Lei, S., Qiu, X., Wang, Z., Zhang, Z., Zha, A., Zhou, Y., Chen, H., Huang, J., & Yu, Z. (2026). Gut microbial H2S promotes metabolic dysfunction in mice via hepatic PPARα suppression. The ISME Journal, 20(1). https://doi.org/10.1093/ismejo/wrag226
Vancouver
Lei S, Qiu X, Wang Z, Zhang Z, Zha A, Zhou Y, et al. Gut microbial H2S promotes metabolic dysfunction in mice via hepatic PPARα suppression. The ISME Journal. 2026;20(1). doi:10.1093/ismejo/wrag226
BibTeX
@article{Lei2026,
author = {Lei, Shibo and Qiu, Xuan and Wang, Zhen and Zhang, Zuyang and Zha, Andong and Zhou, Yaying and Chen, Hao and Huang, Jing and Yu, Zheng},
title = {Gut microbial H2S promotes metabolic dysfunction in mice via hepatic PPARα suppression},
journal = {The ISME Journal},
year = {2026},
volume = {20},
number = {1},
doi = {10.1093/ismejo/wrag226}
}
EUVIMED